Cargando…

Integrating a prospective pilot trial and patient-derived xenografts to trace metabolic changes associated with acute myeloid leukemia

Despite the considerable progress in understanding the molecular bases of acute myeloid leukemia (AML), new tools to link disease biology to the unpredictable patient clinical course are still needed. Herein, high-throughput metabolomics, combined with the other “-omics” disciplines, holds promise i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carrabba, Matteo G., Tavel, Laurette, Oliveira, Giacomo, Forcina, Alessandra, Quilici, Giacomo, Nardelli, Francesca, Tresoldi, Cristina, Ambrosi, Alessandro, Ciceri, Fabio, Bernardi, Massimo, Vago, Luca, Musco, Giovanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086061/ https://www.ncbi.nlm.nih.gov/pubmed/27793157 http://dx.doi.org/10.1186/s13045-016-0346-2

Ejemplares similares

Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia
por: Naldini, Matteo Maria, et al.
Publicado: (2023)

MRD in Venetoclax-Based Treatment for AML: Does it Really Matter?
por: Bernardi, Massimo, et al.
Publicado: (2022)

In silico derived small molecules targeting the finger-finger interaction between the histone lysine methyltransferase NSD1 and Nizp1 repressor
por: Berardi, Andrea, et al.
Publicado: (2020)

P436: CUTTING-EDGE TRANSCRIPTOMICS TO IDENTIFY LEUKEMIA-INTRINSIC AND -EXTRINSIC CORRELATES OF IMMUNE ESCAPE AND POST-TRANSPLANTATION RELAPSE
por: Edoardo Rovatti, Pier, et al.
Publicado: (2023)

Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donors
por: Liberatore, Carmine, et al.
Publicado: (2022)

Enteric Microbiome Markers as Early Predictors of Clinical Outcome in Allogeneic Hematopoietic Stem Cell Transplant: Results of a Prospective Study in Adult Patients
por: Mancini, Nicasio, et al.
Publicado: (2017)

Integrated Multiomic Profiling Identifies the Epigenetic Regulator PRC2 as a Therapeutic Target to Counteract Leukemia Immune Escape and Relapse
por: Gambacorta, Valentina, et al.
Publicado: (2022)

HLA-G Expression on Blasts and Tolerogenic Cells in Patients Affected by Acute Myeloid Leukemia
por: Locafaro, Grazia, et al.
Publicado: (2014)

Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia
por: Greco, R, et al.
Publicado: (2014)

Discovery of 5,5′-Methylenedi-2,3-Cresotic Acid as a Potent Inhibitor of the Chemotactic Activity of the HMGB1·CXCL12 Heterocomplex Using Virtual Screening and NMR Validation
por: De Leo, Federica, et al.
Publicado: (2020)

Structural basis for PHD(V)C5HCH(NSD1)–C2HR(Nizp1) interaction: implications for Sotos syndrome
por: Berardi, Andrea, et al.
Publicado: (2016)

Acute myeloid leukemia xenograft success prediction: Saving time
por: Griessinger, Emmanuel, et al.
Publicado: (2018)

Modeling cell proliferation in human acute myeloid leukemia xenografts
por: Nobile, Marco S, et al.
Publicado: (2019)

The transcription factor HIF2α partakes in the differentiation block of acute myeloid leukemia
por: Magliulo, Daniela, et al.
Publicado: (2023)

The Role of Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Past, Present, and Future Directions
por: Piccini, Matteo, et al.
Publicado: (2023)

Assessing Heterogeneity of Osteolytic Lesions in Multiple Myeloma by (1)H HR-MAS NMR Metabolomics
por: Tavel, Laurette, et al.
Publicado: (2016)

Nanosphere's Verigene(®) Blood Culture Assay to Detect Multidrug-Resistant Gram-Negative Bacterial Outbreak: A Prospective Study on 79 Hematological Patients in a Country with High Prevalence of Antimicrobial Resistance
por: Greco, Raffaella, et al.
Publicado: (2019)

Epigenetic Therapies for Acute Myeloid Leukemia and Their Immune-Related Effects
por: Gambacorta, Valentina, et al.
Publicado: (2019)

Modeling of Chronic Myeloid Leukemia: An Overview of In Vivo Murine and Human Xenograft Models
por: Sontakke, Pallavi, et al.
Publicado: (2016)

Murine models based on acute myeloid leukemia-initiating stem cells xenografting
por: Mambet, Cristina, et al.
Publicado: (2018)

Imetelstat Induces Leukemia Stem Cell Death in Pediatric Acute Myeloid Leukemia Patient-Derived Xenografts
por: Barwe, Sonali P., et al.
Publicado: (2022)

Defective Glucose Metabolism in Polycystic Kidney Disease Identifies A Novel Therapeutic Paradigm
por: Rowe, Isaline, et al.
Publicado: (2013)

Quantitative polymerase chain reaction-based chimerism in bone marrow or peripheral blood to predict acute myeloid leukemia relapse in high-risk patients: results from the KIM-PB prospective study
por: Gambacorta, Valentina, et al.
Publicado: (2020)

AIRE-PHD fingers are structural hubs to maintain the integrity of chromatin-associated interactome
por: Gaetani, Massimiliano, et al.
Publicado: (2012)

Treatment-Free Remission in Chronic Myeloid Leukemia Harboring Atypical BCR-ABL1 Transcripts
por: Dragani, Matteo, et al.
Publicado: (2020)

Mechanisms of Leukemia Immune Evasion and Their Role in Relapse After Haploidentical Hematopoietic Cell Transplantation
por: Rovatti, Pier Edoardo, et al.
Publicado: (2020)

Pamoic acid is an inhibitor of HMGB1·CXCL12 elicited chemotaxis and reduces inflammation in murine models of Pseudomonas aeruginosa pneumonia
por: De Leo, Federica, et al.
Publicado: (2022)

Quality of Response in Acute Myeloid Leukemia: The Role of Minimal Residual Disease
por: Maurillo, Luca, et al.
Publicado: (2019)

P1638: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL (CHIP) IS A RISK FACTOR FOR PULMONARY VASCULAR THROMBOSIS IN PATIENTS WITH COVID-19.
por: Aletti, Federico Mario, et al.
Publicado: (2023)

Systematic review of dasatinib in chronic myeloid leukemia
por: Breccia, Massimo, et al.
Publicado: (2013)

An improved pre-clinical patient-derived liquid xenograft mouse model for acute myeloid leukemia
por: Her, Zhisheng, et al.
Publicado: (2017)

Efficacy of Flotetuzumab in Combination with Cytarabine in Patient-Derived Xenograft Models of Pediatric Acute Myeloid Leukemia
por: Barwe, Sonali P., et al.
Publicado: (2022)

P429: THERAPY-INDUCED SENESCENCE TRIGGERS UPREGULATION OF ANTIGEN PRESENTATION VIA PRC2 INHIBITION AND PROMOTES ANTI-TUMOUR IMMUNITY IN ACUTE MYELOID LEUKAEMIA
por: Gilioli, Diego, et al.
Publicado: (2023)

Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection
por: Caiado, Francisco, et al.
Publicado: (2019)

Disruption of SIRPα signaling in macrophages eliminates human acute myeloid leukemia stem cells in xenografts
por: Theocharides, Alexandre P.A., et al.
Publicado: (2012)

A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia
por: Saland, E, et al.
Publicado: (2015)

PB2426: SORAFENIB MAINTENANCE TAILORED TO FLT3-MUTATED AML AFTER ALLOGENEIC HCT IS HIGHLY FEASIBLE AND EFFECTIVE: A REAL-LIFE EXPERIENCE
por: Diral, Elisa, et al.
Publicado: (2023)

Highly Sensitive Detection of IDH2 Mutations in Acute Myeloid Leukemia
por: Petiti, Jessica, et al.
Publicado: (2020)

Bosutinib for Chronic Myeloid Leukemia
por: Breccia, Massimo, et al.
Publicado: (2015)

Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06
por: Caprioli, Chiara, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fj3kr2uuuomudddsej3k8gge4i